LIMN – liminatus pharma, inc. - class a (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

LIMN

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

3/17

08:08 am

limn

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

Medium Report

Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody

Report

2/17

09:13 am

limn

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering [Yahoo! Finance]

Low Report

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering [Yahoo! Finance]

Report

2/17

08:44 am

limn

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

High Report

Liminatus Pharma, Inc. Announces Pricing of $4.0 Million Public Offering

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.